Abstract:Early precise diagnosis of cancers is crucial to realize more effective therapeutic interventions with minimal toxic effects. Cancer phenotypes may also alter greatly among patients and within individuals over therapeutic process. The identification and characterization of specific biomarkers expressed on tumor cells are highly demanded for diagnosis and treatment, but remain ongoing challenge. Herein, we designed three new bioorthogonal surface enhanced Raman scattering (SERS) nanoprobes and successfully applied the cocktail of them for MDA-MB-231 and MCF-7 breast cancer multiplex phenotype detection. The SERS nanoprobes containing Raman reporters with diynl, azide or cyano moieties demonstrated apparent Raman shift peaks in 2205 cm-1, 2120 cm-1 and 2230 cm-1, respectively, in biologically Raman-silent region. Three target ligands including oligonucleotide aptamer (AS1411), arginine-glycine-aspatic acid (RGD) peptide and homing cell adhesion molecule antibody (anti-CD44) were respectively conjugated to the nanoprobes for active recognition capability. The cocktail of the nanoprobes manifested minimal cytotoxicity and simultaneously multiplex phenotype imaging of MDA-MB-231 and MCF-7 cells. Quantitative measurement of cellular uptake by in-ductively coupled plasma mass spectrometry (ICP-MS) verified that MDA-MB-231 cells harbored much higher expres-sion level of CD44 receptor than MCF-7 cells. For in vivo SERS detection, Raman shift peaks of 2120 cm-1, 2205 cm-1 and 2230 cm-1 in micro tumor were clearly observed, representing the existence of three specific biomarkers of nucleolin, integrin αvβ3 and CD44 reporter, which could be used for early cancer phenotype identification. The biodistribution results indicated that target ligand modified nanoprobes exhibited much more accumulation in tumors than those nanoprobes without target ligands. The multicolor cocktail of bioorthogonal SERS nanoprobes offers an attractive and insightful strategy for early cancer multiplex phenotype targeting and diagnosis in vivo with non-invasion, low cross-talk, unique spectral-molecular signature, high sensitivity and negligible background interference.

Single-band Upconversion Nanoprobes for Multiplexed Simultaneous in Situ Molecular Mapping of Cancer Biomarkers

Multiplexed Detection of Protein Cancer Markers with Biobarcoded Nanoparticle Probes

Simultaneous Detection of Intracellular Tumor Mrna with Bi-Color Imaging Based on a Gold Nanoparticle/molecular Beacon.

Multicolor Cocktail for Breast Cancer Multiplex Phenotype Targeting and Diagnosis Using Bioorthogonal Surface-Enhanced Raman Scattering Nanoprobes.

A multi-channel responsive AuNP@COF core-shell nanoprobe for simultaneous subcellular profiling of multiple cancer biomarkers

Multiplexed Detection of Tumor Biomarkers Utilizing Immunohybridization Chain Reaction Integrated Photonic Barcodes

Fluorescent-magnetic-biotargeting Multifunctional Nanobioprobes for Detecting and Isolating Multiple Types of Tumor Cells.

Multiplexed Detection and Imaging of Intracellular Mrnas Using a Four-Color Nanoprobe.

Simultaneous Surface-Enhanced Raman Spectroscopy Detection of Multiplexed Microrna Biomarkers

Multivalent Capture and Detection of Cancer Cells with Dna Nanostructured Biosensors and Multibranched Hybridization Chain Reaction Amplification

Rational design of nonlinear hybridization immunosensor chain reactions for simultaneous ultrasensitive detection of two tumor marker proteins.

A Novel Microfluidic Chip and Antibody-Aptamer Based Multianalysis Method for Simultaneous Determination of Several Tumor Markers with Polymerization Nicking Reactions for Homogenous Signal Amplification

An Super Sensitive Multi-Modal Controlled Release Biosensor with Label- and Enzyme- Free Assisted Single Step Simultaneously Detect Multiple Breast Cancer Biomarkers

Using aptamer-conjugated fluorescence resonance energy transfer nanoparticles for multiplexed cancer cell monitoring.

Simultaneous sensing of multiple cancer biomarkers by a single DNA nanoprobe in nanopore.

Simultaneous Visualization of Multiple mRNAs and Matrix Metalloproteinases in Living Cells Using a Fluorescence Nanoprobe.

Naked eye detection of multiple tumor-related mRNAs from patients with photonic-crystal micropattern supported dual-modal upconversion bioprobes.

Single-Nanoparticle Differential Immunoassay for Multiplexed Gastric Cancer Biomarker Monitoring

“Three-in-one” Nanohybrids As Synergistic Nanoquenchers to Enhance No-Wash Fluorescence Biosensors for Ratiometric Detection of Cancer Biomarkers

Competitive Aptasensor for the Ultrasensitive Multiplexed Detection of Cancer Biomarkers by Fluorescent Nanoparticle Counting.

SERS-fluorescence joint spectral encoded magnetic nanoprobes for multiplex cancer cell separation.